• Łukasz Zadka, Aleksandra Piotrowska, Agnieszka Opalińska, Katarzyna Haczkiewicz-Leśniak, Damian Grybowski, Ireneusz Ceremuga, Mariusz Chabowski, and Piotr Dzięgiel.
• Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, Wrocław, Poland. ceadr7@gmail.com
• Pol. Arch. Med. Wewn. 2020 Aug 27; 130 (7-8): 640-648.

IntroductionExosomes are currently considered as the new biomarkers of colorectal cancer (CRC). Tetraspanins (CD9, CD63) belong to the well‑known exosome markers, but can also be found on other subtypes of extracellular vesicles (EVs).ObjectivesThe aim of this study was to estimate the expression level of exosome markers and EVs in CRC.Patients And MethodsThe expression level of CD9 and CD63 antigens was evaluated by immunohistochemical staining in 109 patients diagnosed with CRC. Immunohistochemistry results were verified by nanoparticle tracking analysis (NTA), as well as the Western blot analysis and transmission electron microscopy. Exosomes isolation was performed on solid tissues. The immunohistochemical expression of both tetraspanins was compared with expression of cellular p roliferation marker, Ki‑67.ResultsA higher expression level of exosome markers was observed in CRC compared with the normal colonic mucosa. The NTA revealed higher concentrations of nanoparticles in CRC tissues than in controls. There was a strong positive correlation between exosome markers and the Ki‑67 antigen. The expression levels of both tetraspanins were different for lymph node stagi ng (N stage).ConclusionsExosome markers and EVs were more pronounced in the CRC samples compared with controls. Immunohistochemical evaluation of tetraspanins reflects the results obtained by the NTA. Exocytosis appears to play an important role in the pathogenesis of CRC. To the best of our knowledge, such analysis was carried out for the first time.

6 keywords...

hide…